Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-936-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
There is no evidence for a skin sensitising potential of Fatty acids, C18 unsatd., mono and diester with triethanolamine, di-Me sulfate-quaternized based on a weight of evidence including information from OECD 406 guideline studies (Buehler test / Guinea pig maximisation test) with partially unsaturated TEA-Esterquat and oleic acid-based TEA-Esterquat.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1992-06-18 to 1992-07-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- May 12, 1981
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A valid GPMT conducted according to guideline is available, which is reliable without restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- other: Pirbright white Bor:DHPW (SPF)
- Sex:
- male/female
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- intradermal injection: 5 % in aqua ad inject
topical application: 25 % in aqua ad inject - Day(s)/duration:
- intradermal: day 0 / epicutaneous: 7 days after intradermal for 48 h
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 10% in aqua ad inject.
- Day(s)/duration:
- day 21 / 24 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 20 (10 male, 10 female)
- Details on study design:
- RANGE FINDING TESTS:
- Intradermal injection:
The test article was diluted with aqua ad inject. and Freund's complete adjuvant (FCA; Sigma, 8024 Deisenhofen) to give a final concentration of 5 %.
Two animals were employed for the concentration tested, skin reactions were recorded 48 h after treatment.
- Dermal Application:
The test article was used undiluted. A closed patch exposure was effected by means of an occlusive bandage. Since this maximum concentration proved irritating, lower concentrations (75, 50, 25, 10 %) were tested. Ten animals were employed and skin reactions were recorded 48 h post applicationem.
MAIN STUDY
A. INDUCTION EXPOSURE (day 0)
- First stage -an area of 4 x 6 cm over the shoulders was clipped short with electric clippers and cleaned with 70 % (v/v) ethanol. Three pairs of intradermal injections were then made symmetrically in two rows on either side of the spine:
-- Test group:
1. 0.1 ml FCA 50 % (w/w) diluted in aqua ad inject.
2. 0.1 ml test article diluted in aqua ad inject (final concentration: 5 %)
3. 0.1 ml test article diluted in FCA /aqua ad inject (final concentration: 5 %)
-- Control group:
1. 0.1 ml FCA 50 % (w/w) diluted in aqua ad inject
2. 0.1 ml aqua ad inject. (undiluted)
3. 0.1 ml aqua ad inject 50 % (w/w) diluted in FCA
-- Second stage (day 7)
- 7 days after the intradermal injections the dermal application was initiated subsequent to reclipping of the area 24 hours before application of the test article at the highest concentration producing mild to moderate irritation, i.e. (25 % in aqua ad. inject). The test article was spread in a thick layer [to saturation] over a 4 x 5 cm patch (filter paper). The latter was firmly secured over the previous injection sites by an occlusive dressing for 48 h.
Control animals received a patch loaded with the vehicle alone.
B. CHALLENGE EXPOSURE (day 21)
Both control and test animals were subjected to a challenge exposure 14 days after the second stage of induction. The challenge test was performed on a 5 x 5 cm clipped and shaved area on each flank. The maximal non-irritating concentration of the test article (10 % in aqua ad iniect.) was applied to the left flank and the vehicle to the right using the patch technique described. In each case the duration of exposure was 24 h under an occlusive dressing. 24 and 48 h after patch removal, allergic responses were evaluated on a numerical scale according to Draize.
GRADING SYSTEM
Dermal reactions graded for erythema and edema according to grading scale:
No erythema: 0
Very slight erythema (barely perceptible): 1
Well defined erythema: 2
Moderate to severe erythema: 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth): 4
No edema: 0
Very slight edema (barely perceptible): 1
Slight edema (edges well defined by raising): 2
Moderate edema (raised approx 1 mm): 3
Severe edema (raised > 1 mm; beyond area of exposure): 4 - Positive control substance(s):
- yes
- Remarks:
- 2,4 dinitrochlorobenzene (extreme sensitizer) and benzocaine (moderate sensitizer) are tested periodically. The last test with an acceptable level of response to each of these substances was performed in April 1992.
- Positive control results:
- 2,4 dinitrochlorobenzene (extreme sensitizer) and benzocaine (moderate sensitizer) are tested periodically. The last test with an acceptable level of response to each of these substances was performed in April 1992.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- other: periodically tested
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test article "partially unsaturated TEA-Esterquat" is considered to be a non-sensitizer in this study.
- Executive summary:
In a dermal sensitization study according to OECD Guideline 406, May, 12 1981 with partially unsaturated TEA-Esterquat (a.i. 90 %, in isopropanol 10 %) diluted in water young adult Pirbright white guinea pigs (10 male, 10 female) were tested using the MAXIMIZATION TEST method.
Intradermal induction was performed with a 5 % test substance concentration. After dermal induction with 25 % solution of test substance, slight to well defined erythema and oedema was observed. None of the animals of the test group or control group showed any positive skin reactions after challenge treatment with a non-irritating test article concentration of 10 % in water. The sensitization rate at 24 h and at 48 h was 0 %.
The test article is considered to be a non-sensitizer in this study.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1993-10-13 to 1993-11-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- July 17, 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- A valid Buehler test conducted according to guideline is available, which is reliable without restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- other: Pirbright white Bor: DHPW (SPF)
- Sex:
- male/female
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 25% (1st and 2nd exposure) and 10% (3rd exposure)
- Day(s)/duration:
- once weekly for a total of three 6-h exposures
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 10 %
- Day(s)/duration:
- 2 weeks after induction, 6 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- study group 20 (10 male, 10 female)
control group 10 (5 male, 5 female) - Details on study design:
- RANGE FINDING TESTS:
- The test was conducted in two males and two females using Hill-Top Chambers (Hill Top, Cincinnati, USA) secured with rubber dental dam (4D Rubber Co., Ltd.,UK), the test article was applied in concentrations of 100%, 50%, 25% and 10% to discrete areas of clipped skin on the back of the animals (two concentrations per animal). The animals were then immobilized in metal restrainers for 6 h, after which time the patches were removed and the animals returned to their cages. Skin reactions were recorded 24 h and 48 h after patch removal.
MAIN STUDY
A. INDUCTION EXPOSURE
The induction procedure was performed in both the test and the control group. The test article was applied at a concentration of 25% (first and second exposure) and 10% (third exposure) to an area of clipped skin in the left anterior quadrant of the back of each test animal, whilst the control animals were subjected to an exposure with the vehicle at the same site. Method of application and duration of exposure were the same as in the pilot study. The treated skin site of each animal was evaluated 24 h after patch removal to detect dermal irritation. This procedure was repeated on the same site once weekly for a total of three 6-h exposures.
On the basis of the results of the range finding the concentrations of 25% and 10% of the test article were considered to ie suitable for induction exposure and challange exposure, respectively. Because of mmoderate irritation after the second induction exposure the concentration used for the third induction procedure was reduced to 10%.
After the last induction exposure all animals remained untreated for 2 weeks prior to challenge.
B. CHALLENGE EXPOSURE
Both test and control groups were subjected to a challenge exposure with the test article and the vehicle. The test article was applied in a concentration of 10% to a clipped area of skin in the right posterior quadrant of the back and the vehicle was applied in the right anterior quadrant of each animal. Method of application and duration of exposure were the same as in the pilot study. Approximately 21 h after patch removal and 3 h before the first evaluation the skin area was cleared of hair by reclipping. The evaluation of the skin was performed 24 h and 48 h after the end of the exposure period in order to detect possible allergic responses. - Positive control substance(s):
- yes
- Remarks:
- The reaction to the positive control substance 2-mercaptobenzotbiazole is tested periodically. The last test with an acceptable level of response (extreme sensitizer) to this substance at the concentration of 15% in peanut oil was performed in November 19
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- other: periodically tested
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study, the test substance partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
- Executive summary:
In a dermal sensitization study according to OECD Guideline 406, Juli 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90%) in water young adult Pirbright white guinea pig (10 male, 10 female) were tested using the BUEHLER method.
The sensitization rate at 24 h and at 48 h was 0 %
In this study, the test substance partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2004-01-13 to 2004-02-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- July 17, 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- July 30, 1996
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- A valid Buehler test conducted according to guideline is available, which is reliable without restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- other: Ibm: GOHI; SPF-quality (Himalayan spotted)
- Sex:
- male
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 25%, three times at intervals of one week, 6 h exposure
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1%
- Day(s)/duration:
- 14 d after induction, 6 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Total of 38 animals
8 – preliminary screen
10 – main test control
20 – main test treatment - Details on study design:
- PRELIMINARY STUDY AND DOSE RANGE FINDING
Left and right cranial and caudal flanks: 1. test: 50, 25, 15, 10; 2. test: 5, 3, 1 and 0.3% (w/w) 50% of test item was applied in a 25 mm Hill top chamber with a spatula.
25, 15, 10, 5, 3, 1 and 0.3% of test items were applied at 0.5 ml in a 25 mm Hill top chamber.
Application for 6h under fully occluded conditions. The application sites were assessed for erythema and oedema approx. 24 and 48 h after removal of the patches.
INDUCTION
25% (minimally irritating); left cranial and caudal flanks; topical application of aqueous solution for 6h, three times at intervals of one week. Skin grading 24h following patch
removal
CHALLENGE
1% (non-irritating); left cranial and caudal flanks; 14d after the last induction exposure, application of the challenge patch on the shaved skin for 6h; skin evaluations 24 and 48h after patch removal
GRADING SYSTEM
Dermal reactions graded for erythema, edema and other clinical changes in skin condition according to grading scale:
No visible change: 0
Discrete or patchy erythema: 1
Moderated and confluent erythema: 2
Intense erythema and swelling: 3 - Positive control substance(s):
- yes
- Remarks:
- Alpha-Hexylcinnamaldehyde
- Positive control results:
- Result: 20/20 (24 h reading) and 17/20 (48 h reading) test animals were observed with descrete/patchy to moderate/confluent erythema after the challenge treatment with the highest tested non-irritating concentration of Alpha-Hexylcinnamaldehyde at 5 % in PEG 300. No skin effect was observed in the control group.
Conclusion: In this study, 100 % (24 h reading) of the animals of the test group were observed with skin reactions after challenge treatment performed with the highest tested non-irritating concentration of Alpha-Hexylcinnamaldehyde at 5 % in PEG 300. - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 % in purfified wate
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 % in purified water
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 % in purified water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 % in purfied water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- other: periodically tested
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study, the test substance partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
- Executive summary:
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90 % in approx. 10 % isopropanol) diluted in purified water 20 male young adult Himalayan spotted guinea pigs were tested using the Bühler test method.
The sensitization rate at 24 h and at 48 h was 0 %
In this study, the test substance partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1994-02-01 to 1994-03-17
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- July 17, 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- December 29, 1992
- Principles of method if other than guideline:
- Minor deviation: timing of second challenge at 3 % no clear.
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- A valid Buehler test conducted according to guideline is available, which is reliable with restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- female
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 12.5%
- Day(s)/duration:
- 3 times at intervals of one week, 6 h exposure
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1st challenge: 3 %
2nd challenge: 3 % and 1 % - Day(s)/duration:
- 14 d (1st challenge) and 21 d (2nd challenge) after last induction exposure; 6 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 3 – preliminary study (for induction)
5 – dose finding (for challenge)
10 ‐ control
20 – treated - Details on study design:
- PRELIMINARY STUDY AND DOSE FINDING
Preliminary (for induction): left flank: 3, 6, 12.5, 25%
Topical application 0.5 g/plaster (4-6 cm2) aqueous solution (‘viscous to pasty’) for 6h under fully occluded conditions.
Result: Minimally irritating concentration at 12.5%
Dose finding (for challenge): 6, 8, 10, 12%
Topical application 0.5 g/plaster (4-6 cm2) aqueous solution for 6h under fully occluded conditions.
INDUCTION
12.5% (minimally irritating), left cranial flank
Topical application 0.5 g/plaster (4-6 cm2) aqueous solution (‘viscous to pasty’) for 6h under fully occluded conditions, three times at intervals of one week. Skin grading 1 and 24h following patch removal after 3rd induction
CHALLENGE
3% (1st challenge, left and right caudal flanks); 1 % (2nd challenge, left and right caudal flanks); 3% (2nd challenge , right caudal flank only)
14 and 21 days after beginning of last induction (3rd), application of the challenge patch on the shaved skin for 6h; skin evaluation 24, 48 and 72h after patch removal
GRADING SYSTEM
Dermal reactions graded for erythema and edema according to grading scale:
- No reaction: 0
- Partial or slight erythema: 1 (add. grade)
- Weak erythema: 1
- Moderated and diffuse erythema and/or edema: 2
- Strong erythema and/or edema: 3 - Positive control substance(s):
- not specified
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- grande 1 left and/or right flank
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- grade 1 right flank
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- grade 1 right and/or left flank
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 11
- Total no. in group:
- 20
- Clinical observations:
- grade 1 right and/or left flank
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- grade 1 left flank
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- grade 1
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 3
- Total no. in group:
- 10
- Clinical observations:
- grade 1
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- grade 1, only right flank tested
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 9
- Total no. in group:
- 20
- Clinical observations:
- grade 1, only right flank tested
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- grade 1, only right flank tested
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- grade 1, only left flank
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Group:
- positive control
- Remarks on result:
- other: not specified
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- ambiguous due to inconsistent pattern
- Conclusions:
- No conclusion in the report. The study results were evaluated to be ambiguous, due to the partly inconsistent pattern and in most cases rapid fading of response at challenge and re-challenge with 3 % test substance concentration in test and control animals.
- Executive summary:
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with the “partially unsaturated TEA-Esterquat” (a.i. 77 % in isopropanole) diluted in water 20 female young adult Pirbright-Hartley guinea pigs were tested using the Bühler test method.
For Induction a mild to moderate irritating concentration of 12.5 % was used. Challenge was performed with a 3 % dilution on the left and right flank. Grade 1 reactions were observed in 25, 55 and 5 % of test animals on right/ and or left flank at the 24, 48 and 72 hour reading, respectively. In 30 % of negative control animals as well a grade 1 reaction was observed at the 48 hour reading on left and/or right flank and in 10 % on the right flank at 72 hours. At re-challenge on the right flank with the same concentration grade 1 reaction was observed in 25, 45 and 15 % of test animals at 24, 48 and 72 hours, respectively. 20 and 30 % of control animals showed grade 1 reactions at 24 and 48 hours. 72 hours after application no effects were observed.
Re-challenge with 1 % revealed no reactions in negative control animals and no reactions on right flank of test animals. Grade 1 response was seen in 3/20 animals at the 48 hours reading, on the left flank. No reactions were observed at the 24 and 72 hour readings in test animals.
Considering only reactions with a clean control group and values of right flank as recommended by the OECD guideline 406 the results of the re-challenge with 1 % are negative with a sensitisation rate of 0 %. However, positive reactions have been observed at re-challenge with 1 % on the left flank, but only at one time point and with grade 1 in 3 animals. A partly inconsistent pattern and in most cases rapid fading of response was observed at challenge and re-challenge with 3 % test substance concentration in test and control animals.
In conclusion the study results were evaluated to be ambiguous.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1994-03-22 to 1994-05-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- July 17, 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- December 29, 1992
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- A valid Buehler test conducted according to guideline is available, which is reliable with restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- Pirbright-Hartley
- Sex:
- female
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1st induction: 60 %
2nd induction: 50 %
3rd induction: 25 % - Day(s)/duration:
- 3 times at interval of one week, 6 h exposure
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- 1st challenge: 10 %
2nd challenge: 3 % - Day(s)/duration:
- 14 day (1st challenge) and 21 days (2nd challenge) after last induction; 6 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 3 – preliminary study (for induction)
10 ‐ control
5 – dose finding (for challenge)
20 – treated - Details on study design:
- PRELIMINARY STUDY AND DOSE RANGE FINDING
Preliminary (for induction):
Left flank: 6, 12.5, 25, 50%
Right flank: 50, 60, 80, 100%
Appearance: < 6% liquid; 12.5-25% viscous; >50% high viscous
Topical application 0.5 g/plaster (4-6 cm2) aqueous solution (‘viscous to pasty’) for 6h under fully occluded conditions
Dose range (for challenge): 5, 10, 20, 25%
One week prior to challenge in 5 control animals already treated with vehicle.
MAIN STUDY
INDUCTION
1st induction: 60%, left cranial flank
2nd induction: 50%, left cranial flank
3rd induction: 25%, another left skin area behind
(Lowering the concentration by means of experience.)
Control: vehicle was applied to the left cranial flanks
Topical application 0.5 g/plaster (4-6 cm2) aqueous solution (‘viscous to pasty’) for 6h under fully occluded conditions, three times at intervals of one
week. Skin grading 1 and 24h following patch removal for each induction period
CHALLENGE
10% (1st challenge, right and left caudal flanks); 3% (re-challenge; right and left caudal flanks)
14 and 21 days after beginning of last induction, application of the challenge patch on the shaved skin for 6h; skin evaluations 24, 48 and 72h after patch removal
GRADING SYSTEM
Dermal reactions graded for erythema and edema by blind reading according to grading scale:
- No reaction: 0
- Slight erythema: 0+ (add. grade)
- Weak erythema and/or edema: 1
- Moderated and diffuse erythema and/or edema: 2
- Strong erythema and/or edema: 3 - Positive control substance(s):
- not specified
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 11
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 10 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- right and left caudal flanks
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- animals with positive response on both flanks, irrespective of severity
- Remarks on result:
- no indication of skin sensitisation
- Group:
- positive control
- Remarks on result:
- other: not specified
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study, partially unsaturated TEA-Esterquat (a.i. 90 %) is not a dermal sensitizer.
- Executive summary:
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90 %) diluted in purified water 20 female young adult Pirbright-Hartley guinea pigs were tested using the Bühler test method.
Dermal induction was performed at concentrations of 60, 50 and 25 %, due to severity of response the concentration has to be decreased.
At challenge with 10 % test substance on the left and right flank, responses of slight erythema (score 0+, added by the study authors) and weak erythema/edema (score 1) were observed. No response was observed in negative control animals. For evaluation a response was considered positive, when a reaction on both flanks was observed, irrespective of severity. The resulting response rates were 25, 55 and 15 % at the 24, 48 and 72 hour readings, respectively. A consistent response over a period of 2 readings in minimum and a response on the contra lateral flank was observed in 35 % (7/20) of test animals. Re-challenge was performed with a 3 % dilution of the test substance on the left and right flank. Only responses on one flank were observed in 3 animals, most of them with a 0+ score. No reactions were observed in control animals. Due to the failure of response on the contra lateral flank the re-challenge was considered to be negative.
In this study, partially unsaturated TEA-Esterquat is not a dermal sensitizer.
.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1997-03-20 to 1997-05-30
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17th July 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 29 th Dec 1992
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A valid GPMT conducted according to guideline is available, which is reliable without restrictions and adequate for classification and labelling purposes. Potency estimation is not mandatory when existing guideline and GLP conforming data are available, which were conducted before the new annex of the REACH Regulation entered into force. Moreover, no indication for skin sensitisation was observed in this study, thus, no dose response information is needed. For this reason and for reasons of animal welfare no additional LLNA was conducted.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Induction:
interdermal: 1 % test substance
dermal: 20 % test substance - Day(s)/duration:
- dermal epicutaneous induction 7 d afer intradermal; 48 h exposure
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Challenge: 1 % test substance
re-challenge: 1 % test substance - Day(s)/duration:
- day 21 / day 28; 24 h exposure
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Total of 55 animals (28 males and 27 females)
15 – preliminary study (2 animals for intradermal; 13 for topical)
20 – main study treatment group (10 males, 10 females)
10 – main study control (5 males, 5 females)
10 – main study reserve control for 2nd challenge
Route of administration intradermal and topical at induction; topical at challenge - Details on study design:
- PRELIMINARY STUDY
A. Topical application
Irritation assessment following 24h occlusive exposure to test material at 100, 80, 60, 40, 20, 10, 5, 3, 1 and 0.5%; skin assessment 24 and 48h after removal of test substance.
Result: 20% was highest concentration to cause mild to moderate skin irritation. This concentration was selected for topical induction. No alterations were observed with 1% and 0.5%; 1% was selected for challenge.
B. Intradermal
0.1 ml of test substance at 0, 0.25, 0.5, 1, 3 and 5 % applied intradermally, both in physiological saline and in an emulsion made up of Freund’s Complete Adjuvant and physiological saline. Assessments made 24, 48 and 72h and 6 and 8 days post-administration Result: 1% in both vehicles (physiological saline and FCA) selected for intradermal induction.
MAIN STUDY
A. INDUCTION EXPOSURE
Day 0: Treatment group:
− Injection 1: 1:1 mixture (v/v) FCA/physiological saline
− Injection 2: 1% Tetranyl CO/40 in physiological saline
− Injection 3: 1% Tetranyl CO/40 in a 1:1 mixture (v/v) FCA/physiological saline
Control group:
- Injection 1: 1:1 mixture (v/v) FCA/physiological saline
- Injection 2: physiological saline
- Injection 3: 50 % (v/v) formulation of physiological saline in a 1:1 mixture (v/v) FCA/physiological saline
Day 7: Treatment group:
Region, free of fur, was treated topically with a 2 x 4 cm patch of filter paper, fully loaded with a 20% solution of Tetranyl CO/40 in bi-distilled water. Patch was covered by an occlusice bandage and left in place for 48 hours.
Control group:
Only vehicle was applied.
After removal of patches, test aereas were washed with warm water.
B. CHALLENGE EXPOSURE
Day 21: Left flank of all animals, including controls, treated topically with 0.5 ml of 1% test substance for 24h under an occlusive patch. 0.5 ml of vehicle alone applied to right flank.
Day 28: 2nd challenge. Test substance applied at 1% in bidest water to right flank and vehicle to left flank
GRADING SYSTEM
Dermal reactions graded for erythema and edema by blind reading according to grading scale:
No reaction: 0
Mild redness: 1
Moderate erythema: 2
Severe erythema with or without edema: 3 - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
- Positive control results:
- The evaluation of the cutaneous alterations recorded in the treatment group, 24 and 48 h after the end of the exposure to the administered substance revealed that 10 of the 20 animals in the treatment group showed a reaction attributable to a sensibilisation process. the data are comparable to those obtained by Magnusson and Kligman (1969), for the assay with the substance Mercaptobenzothiazole
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 % test substance
- No. with + reactions:
- 3
- Total no. in group:
- 19
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 % test substance
- No. with + reactions:
- 3
- Total no. in group:
- 19
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 % test substance
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 % test substance
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Group:
- positive control
- Remarks on result:
- positive indication of skin sensitisation
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance oleic acid-based TEA-Esterquat can be classified as a non-sensitiser to the guinea pig under the conditions of this study.
- Executive summary:
In a dermal sensitization study with oleic acid-based TEA-Esterquat in bidest. water, young adult male and female Dunkin-Hartley guinea pigs were tested using the method of Magnusson and Kligman according to OECD guideline 406. Positive control material was 2-Mercaptobenzothiazole.
In this study, the test substance oleic acid-based TEA-Esterquat produced a sensitisation rate of 15 % (3/19) at the first challenge and a sensitisation rate of 0 (0/20) at re-challenge at a concentration of 1 % and is considered to be a non-sensitizer.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
The hypothesis for this analogue approach is that target and source substances, being different compounds, have similar (eco) toxicological properties based on structural similarity with common functional groups; a quaternized ethanolamine moiety, one to three ester groups with a typical UVCB distribution with long-chain fatty acids of natural origin.
Furthermore identical precursors (triethanolamine, long-chain fatty acids, dimethyl sulphate) are used for manufacturing. Therefore common breakdown products via physical and biological processes, which result in structurally similar chemicals, are evident.
For further information refer to general justification for read-across attached to chapter 13 of this IUCLID file.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
See general justification for read-across attached to chapter 13 of this IUCLID file.
3. ANALOGUE APPROACH JUSTIFICATION
See general justification for read-across attached to chapter 13 of this IUCLID file.
4. DATA MATRIX
See general justification for read-across attached to chapter 13 of this IUCLID file. - Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across: supporting information
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1-10% in several studies
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1-10% in several studies
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- other: all readings
- Group:
- negative control
- Dose level:
- Controls from different studies
- Remarks on result:
- other: valid
- Key result
- Reading:
- other: all readings
- Group:
- positive control
- Dose level:
- Positive controls from different studies
- Remarks on result:
- other: valid
- Interpretation of results:
- GHS criteria not met
Referenceopen allclose all
RESULTS
Pilot study (range finding):
- Intradermal: No specific findings were observed.
- Dermal:
-- 100, 75 and 50 %: Partly well-defined erythema and slight oedema with induration of the treated areas were observed.
-- 25 %: Slight to well-defined erythema were observed.
-- 10 %: No skin reactions were observed, highest non-irritant concentration.
Main study:
Signs of irritation during induction:
At a concentration of 25 % slight to well-defined erythema and oedema were observed.
Challenge (conc. of test substance: 10 %, left flank) : The sensitization rate at 24 h and at 48 h was 0 %.
No reactions observed in control and test animals at 24 or 48h.
RESULTS
Pilot study (range finding):
- 100 %: moderate to severe erythema (score 3), moderate oedema (score 2)
- 50 %: well-defined and moderate to severe erythema (scores 2 and 3), very slight to slight oedema (scores 1 and 2)
- 25 %: very slight erythema (score 1), no or very slight oedema (scores 0 and 1)
- 10 %: no skin reactions
Main study:
The sensitization rate at 24 h and at 48 h was 0 %.
PRELIMINARY STUDY AND DOSE RANGE FINDING
Concentration for induction: 25% (minimally irritating).
Concentration for challenge:1% (highest non‐irritating dose)
SKIN EFFECTS IN INDUCTION
19/20 (first induction), 20/20 (second and third induction): discrete/patchy to moderate/confluent erythema
0/10 control group: no reactions
SKIN EFFECTS IN CHALLENGE
No skin reaction observed in the control and test animals treated with the test item at 1% in purified water.
PRELIMINARY STUDY
- Minimally irritating concentration at 12.5%
DOSE FINDING
- The result of the dose finding study was a significantly increased irritative sensitivity of the animals therefore concentration for challenge: 3%
Evaluation of dermal effects after challenge with 3 %, re-challenge with 3 and 1 % test substance dilutions in dest. water:
Treatment group:
Animal/ hours |
challenge 3 % |
re-challenge 1 % |
re-challenge 3 % |
||||||||||||
left flank |
right flank |
left flank |
right flank |
right flank |
|||||||||||
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
|
19 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
21 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1# |
0 |
22 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
24 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
25 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0# |
0 |
26 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
27 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
28 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
29 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
30 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
31 |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
32 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
33 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0# |
34 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
35 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
36 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
1 |
37 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
38 |
0 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
# scratch
Negative control animals:
Animal/ hours |
challenge 3 % |
re-challenge 1 % |
re-challenge 3 % |
||||||||||||
left flank |
right flank |
left flank |
right flank |
|
|
|
|||||||||
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
24 |
48 |
72 |
|
4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7 |
0 |
1 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
9 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
10 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
11 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0# |
0 |
12 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0# |
0 |
13 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
# scratch
PRELIMINARY STUDY AND DOSE RANGE FINDING
- Minimally irritating concentration at 60%
-10% concentration for challenge (maximum non‐irritating dose)
Evaluation of dermal effects after challenge with 10 % and re-challenge with 3 % test substance dilutions in dest. water:
Treatment group
Animal/ hours |
challenge 10 % |
re-challenge 3 % |
||||||||||||
left flank |
right flank |
left flank |
right flank |
|||||||||||
24 |
48 |
72 |
144 |
24 |
48 |
72 |
144 |
24 |
48 |
72 |
24 |
48 |
72 |
|
19 |
0+ |
1 |
0+ |
|
1 |
1 |
0+ |
e |
0+ |
0+ |
0+ |
0 |
0 |
0 |
20 |
0 |
0 |
0 |
|
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
21 |
0 |
0 |
0 |
|
0 |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
22 |
1 |
1 |
0+ |
e |
0 |
0+ |
0 |
|
0+ |
0+ |
0 |
0 |
0 |
0 |
23 |
0 |
0 |
0 |
|
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
24 |
1 |
1 |
1 |
|
0 |
1 |
1 |
e |
0 |
0 |
0 |
0 |
0 |
0 |
25 |
0 |
0+ |
0 |
|
0 |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
26 |
0 |
0+ |
0 |
|
0 |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
27 |
1 |
1 |
0+ |
|
0+ |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
28 |
0 |
0+ |
0 |
|
0+ |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
29 |
0 |
0 |
0 |
|
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
30 |
1 |
1 |
1 |
e |
0+ |
0+ |
0+ |
|
0 |
0 |
0 |
0 |
0 |
0 |
31 |
0 |
0 |
0 |
|
0+ |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
32 |
1 |
0+ |
0 |
|
0+ |
0+ |
0+ |
|
0 |
0 |
0 |
0 |
0 |
0 |
33 |
0 |
0+ |
0 |
|
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
34 |
0 |
0 |
0 |
|
1 |
1 |
1 |
e |
0 |
0 |
0 |
1 |
0+ |
1 |
35 |
0+ |
1 |
0+ |
|
1 |
1 |
0+ |
|
0 |
0 |
0 |
0 |
0 |
0 |
36 |
0 |
0 |
0 |
|
0 |
0 |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
37 |
0 |
0+ |
0 |
|
0 |
0+ |
0 |
|
0 |
0 |
0 |
0 |
0 |
0 |
38 |
0 |
0+ |
0 |
|
0+ |
1 |
0+ |
e |
0 |
0 |
0 |
0 |
0 |
0 |
e = eschar; e =strong eschar
An additional score 0+ for slight erythema was added by the study authors.
For evaluation a response was considered positive, when a reaction on both flanks was observed, irrespective of severity.
All readings for negative control group were zero.
Preliminary Study
Topical application:
Result: 20% was highest concentration to cause mild to moderate skin irritation. This concentration was selected for topical induction. No alterations were observed with 1% and 0.5%; 1% was selected for challenge.
Intradermal injections:
Result: 1% in both vehicles (physiological saline and FCA) selected for intradermal induction
Main Study
Mortality:
One male, belonging to the treatment group, was found dead during the induction phase. But the death of this animal did not influence the results of the assay as the minimum number of animals required for the treatment group in assays in which Freud´s Complete Adjuvant is used during the induction phase is 10.
Grades:
1st challenge:
− Grade 1 reaction in 3/19 (15%) animals at 24 and 48h
− reactions in 1/10 (10 %) animals of control group at 24 h reading no effects at 48 h reading
2nd challenge:
- No effects in test or control group
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No experimental data are available for the assessment of sensitizing potential of the target substanceFatty acids, C18 unsatd., mono and diester with triethanolamine , di-Me sulfate-quaternized. However, reliable relevant data are available for the closely related source substances partially unsaturated TEA-Esterquat and oleic acid-based TEA-Esterquat.
Summary
Two Buehler tests with the source substance partially unsaturated TEA-Esterquat were negative, one was judged as ambiguous due to an inconsistent response pattern and in most cases rapid fading of responses at challenge and re-challenge in test and control animals. In one further Buehler test the source substance partially unsaturated TEA-Esterquat was identified as weak sensitiser. Furthermore, two Guinea Pig Maximisation Tests, one conducted with partially unsaturated TEA-Esterquat, the other with oleic acid-based TEA-Esterquat are available, which were both negative.
A weight of evidence approach is used for evaluation. There is no indication from the available specifications to link the weak positive findings in the Buehler studies to differences in the degree of saturation of the underlying alkyl chain in partially unsaturated TEA-Esterquat.
The interpretation of results for those studies which were evaluated to be positive for skin sensitisation were complicated through the occurrence of a partly inconsistent pattern and in most cases rapid fading of response. Evaluation of response was hampered due to irritation and the absence of a clean negative control. Considering the studies with clean negative controls, proper performed induction with 100% test substance or mild to moderate irritating concentrations, there was no (0%) evidence for a skin sensitisation potential.
Studies in detail
In a dermal sensitization study with oleic acid-based TEA-Esterquat in bidest. water, young adult male and female Dunkin-Hartley guinea pigs were tested using the method of Magnusson and Kligman according to OECD guideline 406. Positive control material was 2-Mercaptobenzothiazole.
In this study, the test substance oleic acid-based TEA-Esterquat produced a sensitisation rate of 15 % (3/19) at the first challenge and a sensitisation rate of 0 (0/20) at re-challenge at a concentration of 1 % and is considered to be a non-sensitizer.
In a dermal sensitization study according to OECD Guideline 406, May, 12 1981 with partially unsaturated TEA-Esterquat (a.i. 90 %, in isopropanol 10 %) diluted in water young adult Pirbright white guinea pigs (10 male, 10 female) were tested using the MAXIMIZATION TEST method.
Intradermal induction was performed with a 5 % test substance concentration. After dermal induction with 25 % solution of test substance, slight to well defined erythema and oedema was observed. None of the animals of the test group or control group showed any positive skin reactions after challenge treatment with a non-irritating test article concentration of 10 % in water. The sensitization rate at 24 h and at 48 h was 0 %. The test item is considered to be a non-sensitizer in this study.
In a dermal sensitization study according to OECD Guideline 406, July 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90%) in water young adult Pirbright white guinea pig (10 male, 10 female) were tested using the BUEHLER method.
The sensitization rate at 24 h and at 48 h was 0 %. In this study, the test substance partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90 % in approx. 10 % isopropanol) diluted in purified water 20 male young adult Himalayan spotted guinea pigs were tested using the Bühler test method.
The sensitization rate at 24 h and at 48 h was 0 %. In this study, partially unsaturated TEA-Esterquat is considered to be a non-sensitizer.
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 77 % in isopropanol) diluted in water 20 female young adult Pirbright-Hartley guinea pigs were tested using the Bühler test method.
For Induction a mild to moderate irritating concentration of 12.5 % was used. Challenge was performed with a 3 % dilution on the left and right flank. Grade 1 reactions were observed in 25, 55 and 5 % of test animals on right/ and or left flank at the 24, 48 and 72 hour reading, respectively. In 30 % of negative control animals as well a grade 1 reaction was observed at the 48 hour reading on left and/or right flank and in 10 % on the right flank at 72 hours. At re-challenge on the right flank with the same concentration grade 1 reaction was observed in 25, 45 and 15 % of test animals at 24, 48 and 72 hours, respectively. 20 and 30 % of control animals showed grade 1 reactions at 24 and 48 hours. 72 hours after application no effects were observed.
Re-challenge with 1 % revealed no reactions in negative control animals and no reactions on right flank of test animals. Grade 1 response was seen in 3/20 animals at the 48 hours reading, on the left flank. No reactions were observed at the 24 and 72 hour readings in test animals.
Considering only reactions with a clean control group and values of right flank as recommended by the OECD guideline 406 the results of the re-challenge with 1 % are negative with a sensitisation rate of 0 %. However, positive reactions have been observed at re-challenge with 1 % on the left flank, but only at one time point and with grade 1 in 3 animals. A partly inconsistent pattern and in most cases rapid fading of response was observed at challenge and re-challenge with 3 % test substance concentration in test and control animals. In conclusion the study results were evaluated to be ambiguous.
In a dermal sensitization study according to OECD Guideline 406, July, 17, 1992 with partially unsaturated TEA-Esterquat (a.i. 90 %) diluted in purified water 20 female young adult Pirbright-Hartley guinea pigs were tested using the Bühler test method.
Dermal induction was performed at concentrations of 60, 50 and 25 %, due to severity of response the concentration has to be decreased.
At challenge with 10 % test substance on the left and right flank, responses of slight erythema (score 0+, added by the study authors) and weak erythema/edema (score 1) were observed. No response was observed in negative control animals. For evaluation a response was considered positive, when a reaction on both flanks was observed, irrespective of severity. The resulting response rates were 25, 55 and 15 % at the 24, 48 and 72 hour readings, respectively. A consistent response over a period of 2 readings in minimum and a response on the contra lateral flank was observed in 35 % (7/20) of test animals. Re-challenge was performed with a 3 % dilution of the test substance on the left and right flank. Only responses on one flank were observed in 3 animals, most of them with a 0+ score. No reactions were observed in control animals. Due to the failure of response on the contra lateral flank the re-challenge was considered to be negative.
In conclusion there is evidence for a weak sensitisation potential of partially unsaturated TEA-Esterquat in this study.
Justification for read-across
The read-across is built on the hypothesis that target and source substances, being different compounds, have similartoxicologicalproperties based on structural similaritywith common functional groups.
A detailed justification for read-across is attached to chapter 13 of the IUCLID file.
Similar results were obtained with the source substance MDEA-Esterquat C16-18 and C18 unsatd., results of Human Repeat Insult Patch Tests and supporting data from two Bühler studies with guinea pigs indicate that the substance does not induce skin sensitisation in humans. These data are included into the dossier to demonstrate, that both substances have a similar toxicological profile.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
There is no information available for respiratory sensitisation. Therefore, there is a data gap in this respect. However, the data gap cannot be fulfilled with experimental data, since there is no internationally accepted animal or in vitro model for respiratory sensitisation. In case human data for respiratory sensitisation emerges, this will be taken into account.
Justification for classification or non-classification
Based on the available data,Fatty acids, C18 unsatd., mono and diester with triethanolamine , di-Me sulfate-quaternizeddoes not need to be classified as skin sensitizer according the criteria of CLP, EU GHS (Regulation (EC) No 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.